Registry of Vaccine Responses in Immune Compromised Patients

Launched by LAURE PITTET, MD-PHD · Jun 12, 2024

Keywords

ClinConnect Summary

This clinical trial, called the Registry of Vaccine Responses in Immune Compromised Patients, is looking to understand how vaccines work in patients whose immune systems are weakened. This could be due to conditions like cancer, autoimmune diseases, or treatments that lower immune function. The study aims to track how well these patients respond to vaccines at different stages: right after their diagnosis, before starting treatment, while they’re undergoing treatment, and after their treatment has ended. By gathering this information, researchers hope to improve vaccination strategies for these vulnerable patients.

To participate in this trial, you need to be an immune-compromised patient or someone who is about to become immune-compromised. You’ll also need to provide informed consent, meaning you understand the study and agree to take part. If you have trouble following the study's procedures, like language barriers or certain psychological issues, or if you plan to move away soon, you might not be eligible. If you join, you can expect to help researchers learn more about the effectiveness and safety of vaccines for people with weakened immune systems, which can ultimately benefit many others in similar situations.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Immune compromised patient or patient who will soon be immunocompromised
• • 2. Informed consent as documented by signature
• Exclusion Criteria:
• • 1. Individual/parental inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, known/suspected non-compliance, substance abuse, etc.
• • 2. Plan to move out of the country or have prolong absence in the next 2 months